CASP3 and lung carcinoma: When GSDME is highly expressed, both Cisplatin and Paclitaxel can activate caspase-3 to cut GSDME, and transform the cell death pathway from apoptosis which induced by traditional chemotherapy drugs to pyroptosis, and inhibit the proliferation of lung cancer cells37.